Valuation: Guerbet

Market Cap 93.35M 108M 88.1M 79.92M 150M 10.33B 151M 1.05B 405M 5.24B 405M 396M 16.65B P/E 2026 *
-4.15x
P/E 2027 * 8.05x
Enterprise Value 469M 541M 443M 401M 753M 51.87B 759M 5.29B 2.04B 26.31B 2.03B 1.99B 83.66B EV / Sales 2026 *
0.61x
EV / Sales 2027 * 0.58x
Free-Float
36.58%
Yield 2026 *
-
Yield 2027 * 3.15%
1 day-0.67%
1 week-1.99%
Current month-4.02%
1 month-8.07%
3 months-25.85%
6 months-16.29%
Current year-48.25%
1 week 7.4
Extreme 7.4
7.54
1 month 7.4
Extreme 7.4
8.11
Current year 7.4
Extreme 7.4
15.12
1 year 7.4
Extreme 7.4
18.26
3 years 7.4
Extreme 7.4
40.25
5 years 7.4
Extreme 7.4
45.65
10 years 7.4
Extreme 7.4
90.64
Manager TitleAgeSince
Chief Executive Officer - 2026-02-01
Chief Executive Officer - 2025-09-21
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 44 2015-05-28
Director/Board Member 50 2017-05-18
Director/Board Member 52 2023-11-21
Date Insider Type Main position Quantity % Market Cap. Importance
8/6/26 Buy

Director

1,185 0.0094%
8/5/26 Buy

Director

5,027 0.0398%
8/4/26 Buy

Director

3,788 0.0300%
Change 5-day change 1-year change 3-year change Capi.($)
-0.67%-1.99%-62.40%-63.90% 109M
-0.74%-4.56%-32.26%-1.68% 12.56B
-0.40%-6.12%+10.75%+12.74% 4.13B
-1.25%-8.65%-47.41%-59.49% 1.21B
-0.10%-5.02%-44.24%-43.91% 1.07B
+0.38%-1.10%+15.80%+80.63% 1.05B
+1.31%-7.78% - - 954M
+1.47%-5.72%-40.49% - 953M
+3.07%-3.42%+31.77%+102.94% 489M
-1.36%+8.68%+58.01% - 330M
Average +0.17%-3.36%-12.28%+3.90% 2.29B
Weighted average by Cap. -0.37%-4.39%-20.98%+1.97%

Financials

2026 *2027 *
Net sales 764M 882M 721M 654M 1.23B 84.49B 1.24B 8.61B 3.32B 42.86B 3.31B 3.24B 136B 798M 921M 753M 683M 1.28B 88.3B 1.29B 9B 3.47B 44.79B 3.46B 3.38B 142B
Net income -35.8M -41.32M -33.78M -30.65M -57.5M -3.96B -57.91M -403M -155M -2.01B -155M -152M -6.39B 8.3M 9.58M 7.83M 7.11M 13.33M 918M 13.43M 93.55M 36.05M 466M 35.98M 35.18M 1.48B
Net Debt 376M 433M 354M 322M 603M 41.55B 608M 4.23B 1.63B 21.08B 1.63B 1.59B 67.01B 370M 427M 349M 317M 595M 40.96B 599M 4.17B 1.61B 20.78B 1.61B 1.57B 66.06B
Logo Guerbet
Guerbet is a European leader in producing and selling contrast products for medical imaging. The group's products make it possible to visualize different organs and the lymphatic and vascular systems of the human body by making them opaque. Net sales break down by product family as follows: - X-ray imaging products (54.4%); - MRI products (32.1%); - other (13.5%): contrast products for echography and nuclear medicine, fine chemicals products. At the end of 2024 the group had 8 production sites located in France (4), the United States (2), Ireland and Brazil. Net sales are distributed geographically as follows: Europe/Middle East/Africa (43.8%), Americas (29.7%) and Asia (26.5%).
Employees
2,700
Date Price Change Volume
26-09-14 €7.400 -0.67% 3,295
26-09-11 €7.450 -0.67% 5,663
26-09-10 €7.500 -0.13% 6,544
26-09-09 €7.510 -0.40% 4,647
26-09-08 €7.540 -0.13% 15,559
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
UNDERPERFORM
Number of Analysts
3
Last Close Price
7.400EUR
Average target price
8.433EUR
Spread / Average Target
+13.96%

Quarterly revenue - Rate of surprise

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!